Home > Investor > Financial news

Financial news

E.g., 11/21/2024
E.g., 11/21/2024
2024
November
20 November 2024 Sales revenues for October 2024
October
30 October 2024 Notification according to Art. 89t of the LPOS concerning an increase of the capital of "Sopharma" AD by exercising warrants from the issue ISIN BG9200001212
25 October 2024 Notification on the terms and conditions for distribution of the dividend voted at the Extraordinary General Meeting of Shareholders of "Sopharma" AD held on October 25, 2024
21 October 2024 Sales revenues for September 2024
14 October 2024 Notification according to Art. 89t of the LPOS concerning an increase of the capital of "SOPHARMA" AD, by exercising warrants from the issue with ISIN BG9200001212
4 October 2024 Notification for initiation of acquisition transaction
September
20 September 2024 Sales revenues for August 2024
9 September 2024 Notification of sale of treasury shares as of 9 September 2024
August
20 August 2024 Sales revenues for July 2024
19 August 2024 "Sopharma" AD starts the payment of the dividend for 2023 on August 26, 2024
July
22 July 2024 Sales revenues for June 2024
1 July 2024 Notification of sale of treasury shares as of 1 July 2024
June
28 June 2024 Notification on the terms and conditions for distribution of the dividend
27 June 2024 Notification of sale of treasury shares as of 27 June 2024
26 June 2024 Notification of sale of treasury shares as of 26 June 2024
25 June 2024 Notification of sale of treasury shares as of 25 June 2024
20 June 2024 Sales revenues for May 2024
18 June 2024 Notification of buy-back of treasury shares as of 18 June 2024
17 June 2024 Notification of sale of treasury shares as of 17 June 2024
14 June 2024 Notification of sale of treasury shares as of 14 June 2024
14 June 2024 Notification for a significant shareholding from "Donev Investments Holding" AD as of 14 June 2024
12 June 2024 Notification of sale of treasury shares as of 12 June 2024
May
21 May 2024 Sales revenues for April 2024
April
22 April 2024 Sales revenues for March 2024
March
20 March 2024 Sales revenues for February 2024
February
27 February 2024 Results of conditional capital increase of Sopharma AD by exercising warrants from an issue with ISIN BG9200001212
19 February 2024 Sales revenues for January 2024
January
26 January 2024 Notification according to Art. 89t of the LPOS concerning an increase of the capital of "SOPHARMA" AD by exercising warrants from the issue with ISIN BG9200001212
23 January 2024 Sales revenues for December 2023
15 January 2024 Merger of the subsidiary "Veta pharma" AD into "Sopharma" AD
10 January 2024 "Sopharma" AD starts the payment of the dividend for the 6 months of 2023 on January 22, 2024
2023
December
22 December 2023 Notification for Buy-back of treasury shares on 22.12.2023
22 December 2023 Notification for buy-back of treasury shares on December 21
21 December 2023 Notification for buy-back of treasury shares
21 December 2023 Notification for buy-back of treasury shares
20 December 2023 Notification for buy-back treasury shares
20 December 2023 Sales revenues for November 2023
20 December 2023 Treasury shares December 19, 2023
19 December 2023 Notification for buy-back treasury shares
18 December 2023 Notification for Buy-back treasury shares on 19 December 2023
14 December 2023 Notification for buy-back of treasury shares on December 13, 2023
13 December 2023 Notification for buy-back of treasury shares
12 December 2023 Notification for buy-back of treasury shares
12 December 2023 Treasury shares December 11, 2023
11 December 2023 Notification for buy-back of treasury shares on December 12, 2023
11 December 2023 Treasury shares December 8, 2023
8 December 2023 Notification for buy-back of treasury shares
7 December 2023 Notification for buy-back of treasury shares
4 December 2023 Treasury shares
November
24 November 2023 Notification on the terms and conditions for distribution of the dividend
20 November 2023 Sales revenues for October 2023
7 November 2023 Serbian Commission for Protection of Competition allowed deal with Pharmanova
October
20 October 2023 Sales revenues for September 2023
16 October 2023 Notification for a significant shareholding from CUPF Alianz Bulgaria
16 October 2023 Optimization of the activity in foreign markets
13 October 2023 Notification for a significant shareholding from “Telecomplect Invest” AD
13 October 2023 Notification for a significant shareholding from Ognian Donev
6 October 2023 New capital of "Sopharma" AD entered in the Commercial Register
2 October 2023 Results of conditional capital increase of Sopharma AD by exercising warrants from an issue with ISIN BG9200001212
September
29 September 2023 A transaction concluded by the subsidiary "Pharmalogistika" AD under Art. 114, para. 3 of the LPOS requiring prior approval by the public company
20 September 2023 Sales revenues for August 2023
August
30 August 2023 Notification according to Art. 89t of the LPOS concerning an increase of the capital of "SOFARMA" AD by exercising warrants from the issue with ISIN BG9200001212
23 August 2023 Completion of the infusion conversion procedure of “Biopharm Engineering” AD
21 August 2023 Sales revenues for July 2023
July
26 July 2023 "Sopharma" AD starts the payment of the 2022 dividend on July 31, 2023
20 July 2023 Sales revenues for June 2023
14 July 2023 Initiation of negotiations for potential acquisition of Pharmanova, Republic of Serbia
June
20 June 2023 Sales revenues for May 2023
14 June 2023 Conclusion of transactions from the scope of art. 114, para. 2 of the LPOS
9 June 2023 A transaction concluded by the subsidiary "Pharmalogistika" AD under Art. 114, para. 3 of the Law on Public Offering of Securities requiring prior approval of the public company
6 June 2023 Conditional capital increase in connection with a resolution of the General Meeting of the holders of warrants with ISIN BG9200001212 held on 2 June 2023
2 June 2023 Notification on the terms and conditions for distribution of the dividend
1 June 2023 Analysis of potential acquisition opportunities on the territory of the Republic of Serbia
May
22 May 2023 Sales revenues for April 2023
April
20 April 2023 Sales revenues for March 2023
March
20 March 2023 Sales revenues for February 2023
February
21 February 2023 Notification for share participation from “Telso” AD
21 February 2023 Notification for share participation from “Donev investments holding” AD
6 February 2023 Sales revenues for January 2023
1 February 2023 Dissimination of monthly sales information
January
27 January 2023 "Sopharma" AD submitted for approval to the Financial Supervision Commission for an Agreement for conversion by merger of the subsidiary company "Biopharm-engineering" AD
20 January 2023 Publication of the Tender offering addressed to the shareholders of “Sopharma” AD by “Donev Investments Holding” AD and Opinion of the Board of Directors in connection with Art. 154 of the Law on Public Offering of Securities and Art. 36 of Ordinance 13 o
13 January 2023 Received corrected tender offer addressed to the shareholders of "Sopharma" AD from "Donev Investments Holding" AD
11 January 2023 Sales revenues for December 2022
2022
December
5 December 2022 Sales revenues for November 2022
November
29 November 2022 Conclusion of transactions from the scope of art. 114, para. 2 of the LPOS
28 November 2022 Tender offer to the shareholders of “Sopharma” AD by “Donev Investments Holding” AD
7 November 2022 Sales revenues for October 2022
October
26 October 2022 Merger of the subsidiary "Biopharm-engineering" AD into "Sopharma" AD
5 October 2022 Sales revenues for September 2022
September
29 September 2022 Shareholding notification from “Telso” AD
7 September 2022 Sales revenues for August 2022
August
26 August 2022 Results of the tender offering extended to the shareholders of “Sopharma Properties” REIT
5 August 2022 Sales revenues for July 2022
July
29 July 2022 Sopharma AD extends a tender offering to the shareholders of Sopharma properties REIT
7 July 2022 The Board of Directors of “Sopharma” AD adopted a decision to issue a second warrants issue
5 July 2022 Sales revenues for June 2022
June
14 June 2022 Treasury shares
10 June 2022 Notification under Art. 111 para. 6 of LPOS for repurchase of shares
7 June 2022 Treasury shares
6 June 2022 Sales revenues for May 2022
3 June 2022 Notification under Art. 111 para. 6 of LPOS for repurchase of shares
May
5 May 2022 Sales revenues for April 2022
April
5 April 2022 Sales revenues for March 2022
March
7 March 2022 Sales revenues for February 2022
1 March 2022 Conclusion of transactions from the scope of art. 114, para. 2 of the LPOS
February
7 February 2022 Sales revenues for January 2022
January
18 January 2022 „Sopharma“ AD starts the payment of amounts from the rights with ISIN BG4000006214 sold at service auction
10 January 2022 Sales revenues for December 2021
6 January 2022 Conclusion of transactions from the scope of art. 114, para. 2 of the LPOS
2021
December
30 December 2021 The subscription for the public offering of warrants is successfully completed
23 December 2021 Sale of the share in the capital of the subsidiary SIA „Briz“
21 December 2021 Notification for share participation from “Rompharm Company” OOD
6 December 2021 Sales revenues for November 2021
6 December 2021 Treasury shares
2 December 2021 Notification under Art. 111 para. 6 of LPOS for repurchase of shares
2 December 2021 Treasury shares
November
30 November 2021 Notification under Art. 111 para. 6 of LPOS for repurchase of shares
5 November 2021 Sales revenues for October 2021
5 November 2021 Notification under Art. 89t of LPOS regarding public offering of warrants by “Sopharma” AD
October
5 October 2021 Sales revenues for September 2021
September
30 September 2021 Treasury shares
28 September 2021 Notification under Art. 111 para. 6 of LPOS for repurchase of shares
27 September 2021 Treasury shares
23 September 2021 Notification under Art. 111 para. 6 of LPOS for repurchase of shares
20 September 2021 Treasury shares
16 September 2021 Notification under Art. 111 para. 6 of LPOS for repurchase of shares
13 September 2021 Treasury shares
13 September 2021 Treasury shares
9 September 2021 Notification under Art. 111 para. 6 of LPOS for repurchase of shares
9 September 2021 Sales revenues for August 2021
7 September 2021 Treasury shares
2 September 2021 Notification under Art. 111 para. 6 of LPOS for repurchase of shares
August
5 August 2021 Sales revenues for July 2021
3 August 2021 The Board of Directors of „Sopharma“ AD approved a prospectus for the issue of warrants
July
5 July 2021 Sales revenues for June 2021
June
7 June 2021 Sales revenues for May 2021
1 June 2021 Annual General Meeting of Shareholders convened for 4 June 2021 from 11:00 a.m. (8:00 a.m. UTC)
May
21 May 2021 The Board of Directors of “Sopharma” AD adopted a decision to issue warrants
13 May 2021 Sales revenues for April 2021
April
5 April 2021 Sales revenues for March 2021
2 April 2021 Notification on the adoption of a decision for amendments to the Articles of Association of the Company
March
26 March 2021 Exercising the right to vote by correspondence at the Extraordinary General Meeting of Shareholders convened on 2 April 2021 from 11:00 a.m. (8:00 a.m. UTC)
15 March 2021 Common policy agreement for the management of “Momina krepost” AD
5 March 2021 Sales revenues for February 2021
February
5 February 2021 Sales revenues for January 2021
January
11 January 2021 Sales revenues for December 2020
8 January 2021 „Sopharma” AD now owns 100% of the capital of the subsidiary BRIZ, Latvia
2020
December
29 December 2020 “Sopharma” AD sold the shares of its subsidiary "Aromania" AD
23 December 2020 The Board of Directors gave a mandate for negotiations for the sale of the shares owned by the Company in its subsidiaries "Veta Pharma" AD and "Aromania" AD
7 December 2020 The Investor Relations Director of “Sopharma” AD was awarded "Best Investor Relations Director for 2020" during the most important event of ABIRD - IR AWARDS 2020
7 December 2020 Sales revenues for November 2020
November
16 November 2020 W dniu 23. listopada 2020 spółka Sopharma S.A. rozpoczyna wypłatę dywidendy 6-miesięcznej
5 November 2020 Sales revenues for October 2020
October
5 October 2020 Sales revenues for September 2020
September
30 September 2020 Notification for acquisition of own shares
28 September 2020 Notification on the adoption of a new Policy for formation of the remuneration of the members of the Board of Directors of “Sopharma” AD
28 September 2020 Notification for acquisition of own shares
25 September 2020 Notification for acquisition of own shares
25 September 2020 Notification on the terms and conditions for distribution of the dividend
24 September 2020 Notification for acquisition of own shares
23 September 2020 Notification for acquisition of own shares
14 September 2020 Online meeting with investors and exercising the right to vote by correspondence at the Extraordinary General Meetings of Shareholders convened on 25 September, 2020 from 11:00 and 11:30
8 September 2020 Sales revenues for August 2020
August
5 August 2020 Sales revenues for July 2020
July
22 July 2020 „Sopharma“ AD starts the payment of the gross dividend on August 3, 2020
7 July 2020 Notification for technical error correction
6 July 2020 Sales revenues for June 2020
1 July 2020 Notification for acquisition of own shares
June
30 June 2020 Notification for acquisition of own shares
29 June 2020 Notification for acquisition of own shares
26 June 2020 Notification for acquisition of own shares
25 June 2020 Notification for acquisition of own shares
23 June 2020 Notification for acquisition of own shares
22 June 2020 Notification for acquisition of own shares
19 June 2020 Notification for acquisition of own shares
19 June 2020 Notification for acquisition of own shares
18 June 2020 Notification for technical error correction
16 June 2020 The Board of directors of “Sopharma” AD assigned a procurator of the Company
16 June 2020 Notification for acquisition of own shares
5 June 2020 Sales revenues for May 2020
5 June 2020 Notification on the terms and conditions for distribution of the dividend
2 June 2020 Notification for acquisition of own shares
May
26 May 2020 Online meeting with investors and exercising the right to vote by correspondence at the General Meeting of Shareholders convened on June 5, 2020
5 May 2020 Sales revenues for April 2020
April
29 April 2020 Publishing of the Consolidated Audited Financial Statements for 2019 made public in the terms envisaged in §45, item 2 of the TAP of the Law for the measures and actions under extraordinary circumstances
6 April 2020 Sales revenues for March 2020
March
5 March 2020 Sales revenues for February 2020
February
5 February 2020 Sales revenues for January 2020
January
16 January 2020 Sopharma AD starts the payment of the 6-month dividend on January 22, 2020
10 January 2020 Sales revenues for December 2019
2019
December
20 December 2019 Notification for acquisition of own shares
18 December 2019 Notification for acquisition of own shares
17 December 2019 Notification for acquisition of own shares
16 December 2019 Notification for acquisition of own shares
5 December 2019 Sales revenues for November 2019
November
5 November 2019 Sales revenues for October 2019
October
7 October 2019 Sales revenues for September 2019
September
27 September 2019 Notification for acquisition of own shares
5 September 2019 Sales revenues for August 2019
August
5 August 2019 Sales revenues for July 2019
July
30 July 2019 Main export markets gain speed in H1 2019
5 July 2019 Sales revenues for June 2019
June
5 June 2019 Sales revenues for May 2019
3 June 2019 Notification concerning the Annual General meeting of shareholders – 7 June 2019
May
7 May 2019 Sales revenues for April 2019
  • 313 KB pdf
April
5 April 2019 Sales revenues for March 2019
March
6 March 2019 Sales revenues for February 2019
February
5 February 2019 Sales revenues for January 2019
January
30 January 2019 The shareholding of CUPF Alianz Bulgaria in the capital of Sopharma AD
11 January 2019 Sales revenues for December 2018
2018
December
31 December 2018 Treasury shares
27 December 2018 Treasury shares
19 December 2018 Treasury shares
18 December 2018 Notification for acquisition of own shares
17 December 2018 Treasury shares
14 December 2018 Treasury shares
13 December 2018 Notification for acquisition of own shares
13 December 2018 Notification for acquisition of own shares
12 December 2018 Treasury shares
11 December 2018 Notification for acquisition of own shares
7 December 2018 Treasury shares
6 December 2018 Notification for acquisition of own shares
5 December 2018 Sales revenues for November 2018
5 December 2018 Treasury shares
4 December 2018 Notification for acquisition of own shares
4 December 2018 Notification for acquisition of own shares
November
20 November 2018 Meeting with investors
5 November 2018 Sales revenues for October 2018
1 November 2018 Notification for acquisition of own shares
October
29 October 2018 Notification for acquisition of own shares
25 October 2018 Notification for acquisition of own shares
23 October 2018 Notification for the distribution of bonus shares for the 85th anniversary of Sopharma AD
23 October 2018 Meeting with investors
10 October 2018 Notification on the terms and conditions for payment of the 6-month dividend for the first half of 2018
5 October 2018 Sales revenues for September 2018
September
29 September 2018 Notification for acquisition of own shares
26 September 2018 Notification for acquisition of own shares
25 September 2018 Notification for acquisition of own shares
20 September 2018 Notification for technical error
20 September 2018 Notification for acquisition of own shares
19 September 2018 Notification for acquisition of own shares
18 September 2018 Notification for acquisition of own shares
14 September 2018 Notification for acquisition of own shares
14 September 2018 Notification on the terms and conditions for distribution of the dividend
13 September 2018 Unipharm AD is now merged into Sopharma AD
13 September 2018 Notification for acquisition of own shares
12 September 2018 Notification for acquisition of own shares
11 September 2018 Notification concerning the Extraordinary General meeting of shareholders - 14.09.2018
11 September 2018 Notification for acquisition of own shares
5 September 2018 Sales revenues for August 2018
August
22 August 2018 Notification regarding the terms and conditions for payment of the dividend for 2017 to clients of Beta Corp AD
3 August 2018 Sales revenues for July 2018
July
16 July 2018 Notification on the terms and conditions for payment of the dividend for 2017
5 July 2018 Sales revenues for June 2018
2 July 2018 Notification for acquisition of own shares
June
29 June 2018 Notification for acquisition of own shares
28 June 2018 Notification for acquisition of own shares
27 June 2018 Notification for acquisition of own shares
27 June 2018 Notification for received approval from the FSC of the contract for transformation through merger of Unipharm AD in Sopharma AD
26 June 2018 Notification for acquisition of own shares
25 June 2018 Notification for acquisition of own shares
22 June 2018 Notification for acquisition of own shares
21 June 2018 Notification for acquisition of own shares
20 June 2018 Notification for acquisition of own shares
18 June 2018 Notification for acquisition of own shares
15 June 2018 Notification for acquisition of own shares
15 June 2018 Notification on the terms and conditions for distribution of the dividend
14 June 2018 Notification for acquisition of own shares
5 June 2018 Sales revenues for May 2018
5 June 2018 Notification for acquisition of own shares
May
15 May 2018 Termination of the previous and start a new transformation procedure through the merger of Unipharm AD into Sopharma AD
9 May 2018 Sales revenues for April 2018
3 May 2018 Publication of invitation and materials for AGM
2 May 2018 Issued refusal by the Registry Agency on the transformation through merger between Sopharma AD and Unipharm AD
April
11 April 2018 Notification concerning the General Meeting of Shareholders of Sopharma AD
5 April 2018 Sales revenues for March 2018
March
6 March 2018 Sales revenues for February 2018
1 March 2018 Sopharma Group achieved over BGN 1 billion in sales revenue for the first time in 2017
February
23 February 2018 Decisions taken at the Extraordinary General Meeting of Shareholders of Sopharma AD, held on 23.02.2018
8 February 2018 Notification for acquisition of own shares
5 February 2018 Sales revenues for January 2018
January
30 January 2018 2017 was the best year for Sopharma AD after the crisis
30 January 2018 The shareholding of CUPF Allianz Bulgaria in the capital of Sopharma AD
11 January 2018 Information about a new Sopharma factory in Sofia
9 January 2018 Sales revenues for 2017
2017
December
21 December 2017 Notification for received approval from the FSC of the contract for transformation through merger of Unipharm AD in Sopharma AD
21 December 2017 Notification for acquisition of own shares
18 December 2017 Notification for acquisition of own shares
15 December 2017 Notification for acquisition of own shares
14 December 2017 Notification for acquisition of own shares
8 December 2017 Notification from Rompharm Company OOD
8 December 2017 Notification for acquisition of own shares
8 December 2017 Correction of notification for acquisition of own shares
7 December 2017 Notification for acquisition of own shares
6 December 2017 Notification for acquisition of own shares
4 December 2017 Sales revenues for the eleven months of 2017
November
16 November 2017 Vienna Economic Forum awards Sopharma AD
16 November 2017 BRIZ, a subsidiary of Sopharma, was awarded with the Paracelsus award
6 November 2017 Notification for the Annual meeting with investors
3 November 2017 Sales revenues for the first ten months of 2017
October
5 October 2017 Information for the Annual Meeting with investors
4 October 2017 Sales revenues for the first nine months of 2017
September
29 September 2017 Notification for acquisition of own shares
27 September 2017 Notification from Sopharma AD under Art. 44n of ORDINANCE № 13 of 22.12.2003
25 September 2017 Notification for acquisition of own shares
21 September 2017 Notification for acquisition of own shares
20 September 2017 Notification
19 September 2017 Notification for acquisition of own shares
19 September 2017 Notification
18 September 2017 Notification for acquisition of own shares
15 September 2017 Notification for acquisition of own shares
14 September 2017 Notification for signed contract for transformation through merger between Unipharm AD and Sopharma AD
12 September 2017 Decision of initiation of a procedure for transformation through merger of Unipharm AD in Sopharma AD
12 September 2017 Acquisition of own shares
11 September 2017 Notification
5 September 2017 Sales revenues for the first eight months of 2017
August
4 August 2017 Notification - Sales revenues for the first 7 months of 2017
3 August 2017 Notification
2 August 2017 Notification for the merger between Achieve Life Sciences, Inc. and OncoGenex Pharmaceuticals
July
31 July 2017 Notification
21 July 2017 Sopharma AD acquired 75% from the capital of Aromania
17 July 2017 Earlier date of dividend payment
4 July 2017 Sales revenues for the first six months of 2017
June
21 June 2017 Notification for tender offer submitted by Sopharma AD to the shareholders of Unipharm AD
15 June 2017 Notification for merger between Achieve Life Sciences and Oncogenex
12 June 2017 Dividend payments
8 June 2017 Notification for acquisition
5 June 2017 Sales revenues for the first five months of 2017
2 June 2017 Notification for the amount and type of dividend
May
5 May 2017 Notification for updated invitation to the AGM - 02.06.2017
3 May 2017 Sales revenues for the first four months of 2017
2 May 2017 Notification for technical mistake in the invitation concerning the second date for the AGM
April
20 April 2017 Extraordinary General Meeting - 24 April 2017
18 April 2017 Sopharma AD acquired 51% of the Moldova pharmaceutical distributor RAP Pharma International
6 April 2017 Notification
4 April 2017 Sales revenues for the first quarter of 2017
March
9 March 2017 Notification
7 March 2017 Sales revenues for the first two months of 2017
February
27 February 2017 Notification
3 February 2017 Sales revenues for January 2017
January
9 January 2017 Sales revenues 2016
6 January 2017 Notification
2016
December
15 December 2016 Notification for tender offer
5 December 2016 Sales revenues - November 2016
November
18 November 2016 Notification for disclosure of share participation
16 November 2016 Notification for disclosure of share participation
11 November 2016 Sopharma AD has acquired a total of 68% of the capital of Veta Pharma AD
4 November 2016 Sales revenues - October 2016
4 November 2016 Notification about the decision of the Board of directors to purchase up to 100% of the share capital of "Veta Pharma" AD
October
17 October 2016 Quarterly financial statements and new web site
7 October 2016 Interest in acquiring a commercial company
6 October 2016 Revenues from sales
5 October 2016 Sale of Shares
4 October 2016 Information about treasury shares
September
29 September 2016 Information about treasury shares
27 September 2016 Information about treasury shares
20 September 2016 Information about Annual Meeting with Investors
15 September 2016 Information about treasury shares
12 September 2016 Acquisition of shares
2 September 2016 Revenues from sales
August
18 August 2016 Contractual Relationship with Service Financial Markets EOOD
16 August 2016 Financial information disclosure
10 August 2016 Information about treasury shares
5 August 2016 Sales revenues for July
5 August 2016 Information about treasury shares
2 August 2016 Information about treasury shares
July
29 July 2016 Information about treasury shares
27 July 2016 Paying of dividends
21 July 2016 Information about treasury shares
14 July 2016 Information about treasury shares
4 July 2016 Sales revenues for First Half of 2016
June
16 June 2016 General Meeting of Shareholders of Sopharma AD
6 June 2016 Sales revenues for May 2016
May
11 May 2016 Sales revenues for April 2016
10 May 2016 Notification
8 May 2016 Sopharma Ukraine OOD
April
28 April 2016 Notification
5 April 2016 Sales revenues for March 2016
March
5 March 2016 Information about treasury shares
2 March 2016 Sales revenues for February 2016
February
6 February 2016 Information about treasury shares
4 February 2016 Sales revenues for January 2016
January
22 January 2016 Agreement for termination of the Contract for transformation through merger
21 January 2016 Information about treasury shares
13 January 2016 Sopharma’s Commercial Director has left the management of the Company
11 January 2016 Sales revenues for December 2015
2015
December
4 December 2015 Information about treasury shares
November
5 November 2015 Sales revenues for Оctober 2015
October
26 October 2015 Disclosure of shareholdings
8 October 2015 Notification
5 October 2015 Sales revenues for September 2015
September
28 September 2015 Boad of Directors
23 September 2015 Board of Directors
10 September 2015 Information about treasury shares
4 September 2015 Sales revenues for August 2015
August
27 August 2015 Information about treasury shares
6 August 2015 Information about treasury shares
5 August 2015 Sales revenues for July 2015
5 August 2015 Disclosure of shareholdings
4 August 2015 Disclosure of shareholdings
July
30 July 2015 Information about treasury shares
30 July 2015 Disclosure of shareholdings
20 July 2015 Disclosure of shareholdings
16 July 2015 Information about treasury shares
9 July 2015 Results of the tender offering for the shares of Momina Krepost AD
3 July 2015 Sales revenues for June 2015
1 July 2015 An announcement related to the results of the tender offer for the shares of Momina Krepost AD
June
19 June 2015 Decisions of AGM of shareholders of Sopharma AD
18 June 2015 Information about treasury shares
15 June 2015 Information about AGM of Sopharma AD
12 June 2015 Board of Directors
5 June 2015 Sales revenues for May 2015
May
28 May 2015 Information about treasury shares
21 May 2015 Information about treasury shares
19 May 2015 Notification
15 May 2015 Board of Directors
5 May 2015 Disclosure of shareholdings
April
7 April 2015 Sales revenues for April 2015
3 April 2015 Sales revenues for March 2015
2 April 2015 Information about treasury shares
March
26 March 2015 Information about treasury shares
26 March 2015 A draft tender offer for the purchase of all shares of the other shareholders of Momina Krepost AD
19 March 2015 Notifications for disclosure of share participation
12 March 2015 Information about treasury shares
10 March 2015 Disclosure of share participation
6 March 2015 Registration of the capital increase
5 March 2015 Sales revenues for February 2015
February
26 February 2015 Information about treasury shares
26 February 2015 Registration of the transformation through merger of Bulgarian Rose – Sevtopolis AD in Sopharma AD with Commercial Register
19 February 2015 Information about treasury shares
12 February 2015 Information about treasury shares
5 February 2015 Information about treasury shares
5 February 2015 Sales revenues for January 2015
January
29 January 2015 Information about treasury shares
22 January 2015 Information about treasury shares
15 January 2015 Information about treasury shares
9 January 2015 EGM - 9 January 2015
8 January 2015 Information about treasury shares
8 January 2015 Sales revenues for December 2014
2014
December
18 December 2014 Information about treasury shares
12 December 2014 Information about treasury shares
8 December 2014 Sales revenues for November 2014
4 December 2014 Information about treasury shares
November
27 November 2014 Information about treasury shares
20 November 2014 Information about treasury shares
13 November 2014 Information about treasury shares
10 November 2014 Approved contract for transformation through merger
6 November 2014 Information about treasury shares
5 November 2014 Sales revenues for October 2014
4 November 2014 Disclosure of shareholdings
3 November 2014 Disclosure of shareholdings
October
29 October 2014 Information about treasury shares
23 October 2014 Information about treasury shares
16 October 2014 Information about treasury shares
9 October 2014 Information about treasury shares
3 October 2014 Sales revenues for September 2014
September
25 September 2014 Information about treasury shares
18 September 2014 Information about treasury shares
11 September 2014 Information about treasury shares
5 September 2014 Sales revenues for August 2014
5 September 2014 Paying of dividends for 2013
4 September 2014 Information about treasury shares
August
28 August 2014 Information about treasury shares
21 August 2014 Information about treasury shares
14 August 2014 Information about treasury shares
7 August 2014 Information about treasury shares
5 August 2014 Sales revenues for July 2014
July
31 July 2014 Information about treasury shares
24 July 2014 Information about treasury shares
17 July 2014 Information about treasury shares
10 July 2014 Information about treasury shares
4 July 2014 Sales revenues for June 2014
3 July 2014 Information about merger agreement
3 July 2014 Information about treasury shares
June
20 June 2014 Information about treasury shares
19 June 2014 Information about treasury shares
16 June 2014 AGM
16 June 2014 Initiation of a procedure for merging Bulgarian Rose – Sevtopolis AD
12 June 2014 Information about treasury shares
5 June 2014 Sales revenues for May 2014
May
9 May 2014 Sales revenues for April 2014
April
24 April 2014 Information about treasury shares
17 April 2014 Information about treasury shares
10 April 2014 Information about treasury shares
4 April 2014 Sales revenues for March 2014
March
27 March 2014 Information about treasury shares
20 March 2014 Information about treasury shares
13 March 2014 Information about treasury shares
5 March 2014 Sales revenues for February 2014
February
27 February 2014 Information about treasury shares
20 February 2014 Information about treasury shares
13 February 2014 Information about treasury shares
12 February 2014 Disclosure of shareholdings
10 February 2014 Disclosure of shareholdings
7 February 2014 Disclosure of shareholdings
5 February 2014 Sales revenues for January 2014
January
30 January 2014 Information about treasury shares
23 January 2014 Information about treasury shares
16 January 2014 Information about treasury shares
9 January 2014 Information about treasury shares
2013
December
19 December 2013 Information about treasury shares
12 December 2013 Information about treasury shares
9 December 2013 Implementation of innovative products in the ampoule production of Sopharma AD
3 December 2013 Investment in the capital increase of Briz (Riga, Latvia)
November
28 November 2013 Information about treasury shares
21 November 2013 Information about treasury shares
14 November 2013 Information about treasury shares
7 November 2013 Information about treasury shares
5 November 2013 Sales revenues for October 2013
October
31 October 2013 Cozy place for reading and relaxing at Sopharma AD
31 October 2013 Information about treasury shares
24 October 2013 Information about treasury shares
17 October 2013 Information about treasury shares
10 October 2013 Information about treasury shares
4 October 2013 Sales revenues for September 2013
3 October 2013 Information about treasury shares
September
26 September 2013 Information about treasury shares
19 September 2013 Information about treasury shares
12 September 2013 Information about treasury shares
10 September 2013 Disclosure of shareholdings
5 September 2013 Information about treasury shares
5 September 2013 Sales revenues for August 2013
August
29 August 2013 Information about treasury shares
22 August 2013 Information about treasury shares
15 August 2013 Information about treasury shares
8 August 2013 Information about treasury shares
5 August 2013 Sales revenues for July 2013
1 August 2013 Information about treasury shares
1 August 2013 Disclosure of shareholdings
July
25 July 2013 Information about treasury shares
18 July 2013 Information about treasury shares
12 July 2013 Paying of dividents
11 July 2013 Information about treasury shares
5 July 2013 Sales revenues for June 2013
4 July 2013 Information about treasury shares
4 July 2013 Disclosure of shareholdings
June
27 June 2013 Information about treasury shares
24 June 2013 AGM - decisions
20 June 2013 Information about treasury shares
17 June 2013 Information about AGM 2013
13 June 2013 Information about treasury shares
6 June 2013 Information about treasury shares
6 June 2013 Disclosure of shareholdings
5 June 2013 Sales revenues for May 2013
May
30 May 2013 Information about treasury shares
23 May 2013 Information about treasury shares
18 May 2013 Information about treasury shares
13 May 2013 Sale of all shares representing 85% of the capital of Extab Corporation
9 May 2013 Information about treasury shares
8 May 2013 Sales revenues for April 2013
3 May 2013 Annual Meeting
April
30 April 2013 Disclosure of shareholdings
26 April 2013 Results for April
25 April 2013 Information about treasury shares
18 April 2013 Information about treasury shares
11 April 2013 Information about treasury shares
4 April 2013 Tender offer
4 April 2013 Information about treasury shares
4 April 2013 Sales revenues for March 2013
March
28 March 2013 Information about treasury shares
21 March 2013 Information about treasury shares
21 March 2013 Disclosure of shareholdings
14 March 2013 Information about treasury shares
7 March 2013 Information about treasury shares
5 March 2013 Sales revenues for February 2013
February
28 February 2013 Information about treasury shares
21 February 2013 Information about treasury shares
15 February 2013 Disclosure of shareholdings
14 February 2013 Information about treasury shares
7 February 2013 Information about treasury shares
5 February 2013 Sales revenues for January 2013
January
31 January 2013 Information about treasury shares
24 January 2013 Information about treasury shares
24 January 2013 EGM
23 January 2013 Disclosure of shareholdings
23 January 2013 Disclosure of shareholdings
17 January 2013 Information about treasury shares
10 January 2013 Sales revenues for December 2012
7 January 2013 Information about treasury shares
2012
December
21 December 2012 Disclosure of shareholdings
19 December 2012 Information about treasury shares
5 December 2012 Sales revenues for November 2012
November
29 November 2012 Information about treasury shares
26 November 2012 Disclosure of shareholdings
22 November 2012 Information about treasury shares
21 November 2012 Disclosure of shareholdings
15 November 2012 Information about treasury shares
5 November 2012 Sales revenues for Octomber 2012
2 November 2012 EGM
1 November 2012 Information about treasury shares
October
31 October 2012 Notification about a merger agreement
30 October 2012 Merger agreement between Sopharma AD and Bulgarian Rose – Sevtopolis AD
25 October 2012 Information about treasury shares
18 October 2012 Information about treasury shares
11 October 2012 Information about treasury shares
5 October 2012 Sales revenues for September 2012
4 October 2012 Information about treasury shares
September
27 September 2012 Information about treasury shares
26 September 2012 EGM
21 September 2012 Information about treasury shares
21 September 2012 Information about treasury shares
21 September 2012 Invitation and Materials for EGM
13 September 2012 Information about treasury shares
10 September 2012 Information about treasury shares
4 September 2012 Sales revenues for August 2012
August
30 August 2012 Information about treasury shares
23 August 2012 Information about treasury shares
22 August 2012 Paying of dividents
16 August 2012 Information about treasury shares
8 August 2012 Information about treasury shares
3 August 2012 Sales revenues for July 2012
2 August 2012 Information about treasury shares
July
26 July 2012 Information about treasury shares
5 July 2012 Sales revenues for June 2012
June
27 June 2012 Information about treasury shares
20 June 2012 AGM
15 June 2012 Business Partner of 2012
14 June 2012 Information about treasury shares
6 June 2012 Information about treasury shares
5 June 2012 Sales revenues for May 2012
May
28 May 2012 Information about treasury shares
17 May 2012 Information about treasury shares
9 May 2012 Information about treasury shares
4 May 2012 Sales revenues for April 2012
April
25 April 2012 Information about treasury shares
19 April 2012 Information about treasury shares
18 April 2012 Disclosure of shareholdings
11 April 2012 Information about treasury shares
5 April 2012 Sales revenues for March 2012
March
7 March 2012 Information about treasury shares
5 March 2012 Sales revenues for February 2012
1 March 2012 Information about treasury shares
February
20 February 2012 In an article dated February 4, 2012
2 February 2012 Sales revenues for January 2012
January
30 January 2012 Sopharma issued its Q4 2011
27 January 2012 Information about treasury shares
18 January 2012 Information about treasury shares
13 January 2012 Disclosure of shareholdings
6 January 2012 ACQUISITION OF OWN SHARES
5 January 2012 Sales revenues for December 2011